Efepoetin Alfa for Anemia in Chronic Kidney Disease on Dialysis

We are studying whether efepoetin alfa can effectively manage anemia in patients with chronic kidney disease on dialysis, compared to another treatment. This trial will also assess safety and quality of life for participants.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Aranesp
Aranesp is a medicine used to treat anemia by helping the body make more red blood cells, often for kidney disease or chemotherapy.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Darbepoetin Alfa
Darbepoetin alfa is a substance that stimulates red blood cell production to treat anemia related to kidney disease or chemotherapy.
Epoetin Alfa
Epoetin alfa is a substance that stimulates the body to produce red blood cells to treat anemia.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Gx-E4

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Mnogoprofilna Bolnitsa Za Aktivno Lechenie Puls AD
Hemodialysis department - dialysis treatment
Blagoevgrad, Bulgaria
Umbal - Prof. D-R Stoyan Kirkovich AD
Hemodialysis department - dialysis treatment
Kardzhali, Bulgaria
First Dialysis Services Bulgaria EAD
Dialysis sector
Montana, Bulgaria

Sponsor: Genexine Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.